Literature DB >> 18070223

Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.

Ushma Mehta1, David N Durrheim, Marc Blockman, Tamara Kredo, Ronald Gounden, Karen I Barnes.   

Abstract

UNLABELLED: What is already known about this subject. Studies conducted primarily in developed countries have shown that adverse drug reactions (ADRs) are a significant cause of hospital admission, prolong hospital stay and consequently increase the cost of disease management in patients. Cardiovascular medicines, hypoglycaemic agents, nonsteroidal anti-inflammatory drugs and antibiotics are the most frequently implicated medicines in these studies. A large proportion of these ADRs have been shown to be preventable through improved drug prescribing, administration and monitoring for adverse effects. What this paper adds. This is the first Sub-Saharan African study in the HIV/AIDS era that describes the contribution of ADRs to patient morbidity, hospitalisation and mortality. Cardiovascular medicines and antiretroviral therapy contributed the most to community-acquired ADRs at the time of hospital admission while medicines used for opportunistic infections (such as antifungals, antibiotics and antituberculosis medicines were most frequently implicated in hospital acquired ADRs. ADRs in HIV-infected patients were less likely to be preventable. AIMS: To describe the frequency, nature and preventability of community-acquired and hospital-acquired adverse drug reactions (ADRs) in a South African hospital serving a community with a high prevalence of human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome.
METHODS: A 3-month prospective observational study of 665 adults admitted to two medical wards.
RESULTS: Forty-one (6.3%) patients were admitted as a result of an ADR and 41 (6.3%) developed an ADR in hospital. Many of the ADRs (46.2%) were considered preventable, although less likely to be preventable in HIV-infected patients than in those with negative or unknown HIV status (community-acquired ADRs 2/24 vs. 35/42; P < 0.0001; hospital-acquired ADRs 3/25 vs. 14/26; P = 0.003). Patients admitted with ADRs were older than patients not admitted with an ADR (median 53 vs. 42 years, P = 0.003), but 60% of community-acquired ADRs at hospital admission were in patients <60 years old. Among patients <60 years old, those HIV infected were more likely to be admitted with an ADR [odds ratio (OR) 2.32, 95% confidence interval (CI) 1.17, 4.61; P = 0.017]. Among HIV-infected patients, those receiving antiretroviral therapy (ART) were more likely to be admitted with an ADR than those not receiving ART (OR 10.34, 95% CI 4.50, 23.77; P < 0.0001). No ART-related ADRs were fatal. Antibiotics and drugs used for opportunistic infections were implicated in two-thirds of hospital-acquired ADRs.
CONCLUSIONS: ADRs are an important, often preventable cause of hospitalizations and inpatient morbidity in South Africa, particularly among the elderly and HIV-infected. Although ART-related injury contributed to hospital admissions, many HIV-related admissions were among patients not receiving ART, and many ADRs were associated with medicines used for managing opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070223      PMCID: PMC2291259          DOI: 10.1111/j.1365-2125.2007.03034.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  34 in total

1.  Adverse reactions to drugs as a cause of admissions to a general teaching hospital in Hong Kong.

Authors:  T Y Chan; J C Chan; B Tomlinson; J A Critchley
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

2.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

3.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

Review 5.  Adverse effects of antiretroviral therapy.

Authors:  A Carr; D A Cooper
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

6.  [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].

Authors:  Gabriel Tribiño; Carlos Maldonado; Omar Segura; Jorge Díaz
Journal:  Biomedica       Date:  2006-03       Impact factor: 0.935

7.  Evaluation of outpatient adverse drug reactions leading to hospitalization.

Authors:  Wenchen Kenneth Wu; Nicholas Pantaleo
Journal:  Am J Health Syst Pharm       Date:  2003-02-01       Impact factor: 2.637

Review 8.  Nature of preventable adverse drug events in hospitals: a literature review.

Authors:  Penkarn Kanjanarat; Almut G Winterstein; Thomas E Johns; Randy C Hatton; Ricardo Gonzalez-Rothi; Richard Segal
Journal:  Am J Health Syst Pharm       Date:  2003-09-01       Impact factor: 2.637

9.  Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease.

Authors:  G E Harb; B K Alldredge; R Coleman; M A Jacobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-08

10.  Adverse drug reactions: a cohort study in internal medicine units at a university hospital.

Authors:  Aline Lins Camargo; Maria Beatriz Cardoso Ferreira; Isabela Heineck
Journal:  Eur J Clin Pharmacol       Date:  2006-01-05       Impact factor: 3.064

View more
  48 in total

1.  Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.

Authors:  T M Dodgen; C De J Labuschagne; A van Schalkwyk; F E Steffens; A Gaedigk; A D Cromarty; M Alessandrini; M S Pepper
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Minimising harm: human variation and adverse drug reactions (ADRs).

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-04       Impact factor: 4.335

3.  Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda.

Authors:  W A Tumwikirize; J W Ogwal-Okeng; A Vernby; W W Anokbonggo; L L Gustafsson; S C Lundborg
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

4.  Pharmacovigilance: A public health priority for South Africa.

Authors:  Ushma Mehta; Emma Kalk; Andrew Boulle; Portia Nkambule; Joey Gouws; Helen Rees; Karen Cohen
Journal:  S Afr Health Rev       Date:  2017-08-23

Review 5.  Immunosenescence and hurdles in the clinical management of older HIV-patients.

Authors:  Marco Ripa; Stefania Chiappetta; Giuseppe Tambussi
Journal:  Virulence       Date:  2017-02-21       Impact factor: 5.882

6.  Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis.

Authors:  Parvati B Patel; Tejas K Patel
Journal:  Eur J Clin Pharmacol       Date:  2019-06-11       Impact factor: 2.953

7.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

8.  CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women.

Authors:  Carola R Röhrich; Britt I Drögemöller; Ogechi Ikediobi; Lize van der Merwe; Nelis Grobbelaar; Galen E B Wright; Nathaniel McGregor; Louise Warnich
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-29       Impact factor: 2.205

Review 9.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

10.  Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.

Authors:  Teresa K Smith de Cherif; Jan H Schoeman; Susan Cleary; Graeme A Meintjes; Kevin Rebe; Gary Maartens
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.